Crohn's disease and ulcerative colitis are two distinct forms of inflammatory bowel disease with different locations, complications, and treatments. Learn how they differ in symptoms, diagnosis, and long-term management.
DOACs like apixaban and rivaroxaban require precise dosing adjustments in kidney disease to avoid bleeding or clots. Learn the exact rules for each drug, why Cockcroft-Gault matters more than eGFR, and how to safely manage patients with renal impairment.
Managing warfarin requires consistent vitamin K intake-not restriction. Learn how steady eating keeps your INR in range, reduces bleeding and clot risks, and improves long-term safety without avoiding healthy foods.
In my latest blog post, I've delved into the pharmacokinetics of besifloxacin, a powerful antibiotic used to treat bacterial infections. Through my research, I discovered that its absorption occurs rapidly after administration, allowing it to effectively reach the site of infection. Once absorbed, besifloxacin is distributed throughout the body, binding to proteins in plasma and tissues. As for metabolism, it undergoes minimal transformation, with most of the drug remaining unchanged. Finally, I learned that besifloxacin is primarily excreted through the kidneys, ensuring efficient elimination from the body.
Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, driving development of life-saving medicines that would otherwise be too costly to produce. Learn how it works, who benefits, and why it's here to stay.